Autres langues BioNTech SE Boerse Muenchen

Actions

22UA

US09075V1026

Recherche biotechnologique et médicale

Marché Fermé - Boerse Muenchen 22:43:44 31/08/2026			Varia. 5j.	Varia. 1 janv.
87,25 ^EUR	-0,91%		-11,95%	+8,30%

28/08	BioNTech SE et Genentech mettent fin à l'essai clinique de phase 2 sur l'autogene cevumeran dans le cancer colorectal réséqué	CI
28/08	BioNTech met fin à un essai clinique de phase 2 dans le cancer colorectal ; le titre chute	MT

Autres langues

28/08	Health Care Down, But not by Much, on Rotation Out of Rate-Sensitive Areas - Health Care Roundup
28/08	BioNTech SE And Genentech Terminate Phase 2 Clinical Trial Collaboration For Autogene Cevumeran In Resected Colorectal Cancer
28/08	Wall Street voelt lichte rentevrees na 'hawkish' Jackson Hole-toespraak Warsh
28/08	Sector Update: Healthcare Stocks Decline Late Afternoon
28/08	BioNTech sinks after halting a colorectal cancer study
28/08	Aktien New York Schluss: Signale für US-Zinserhöhung belasten Nasdaq
28/08	BioNTech Terminates Phase 2 Colorectal Cancer Clinical Trial; Shares Fall
28/08	MÄRKTE USA/Knapp behauptet - Zinsen am kurzen Ende ziehen nach Warsh-Rede an
28/08	FDA genehmigt saisonale Covid-19-Impfstoffe von Biontech und anderen
28/08	Upbeat Economic Outlook Buoys Swiss Market Index
28/08	Germany's DAX Index Extends Gains; BioNTech Tumbles After Scrapping Cancer Vaccine Trial
28/08	Top Midday Stories: Warsh Says Inflation Data 'Concerning'; Advent, Stripe Drop $50 Billion Bid to Buy PayPal
28/08	BioNTech stoppt klinische Studie zu Darmkrebs-Therapie
28/08	FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax -- Update
28/08	European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
28/08	Aktien New York: Warsh-Aussagen zur Inflation bremsen die Kurse
28/08	BioNTech, Roche Abandon Mid-stage Cancer Vaccine Trial
28/08	Biontech bricht Studie zu mRNA-Darmkrebstherapie ab
28/08	BioNTech, Roche Abandon Mid-stage Cancer Vaccine Trial
28/08	Afternoon Meeting: Warsh entra en escena
28/08	BioNTech Shares Fall After Ending Phase 2 Colorectal Cancer Trial
28/08	BioNTech Terminates Phase 2 Trial of Autogene Cevumeran in Colorectal Cancer
28/08	BioNTech halts mRNA colorectal cancer vaccine trial after safety review
28/08	Warsh Takes the Stage
28/08	Morning Meeting: Zwei Märkte, zwei Geschichten